Eikon Therapeutics, Inc. (EIKN) Stock Forecast & Price Target
30 Followers
EIKN Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Eikon Therapeutics, Inc. in the past 3 months
EIKN Stock 12 Month Forecast
Average Price Target
$29.00▲(396.58% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Eikon Therapeutics, Inc. in the last 3 months. The average price target is $29.00 with a high forecast of $32.00 and a low forecast of $23.00. The average price target represents a 396.58% change from the last price of $5.84.
Past 12 Months12 Month ForecastJan2026Oct2026
High$32.00
Average$29.00
Low$23.00
Highest Price TargetHighest$32.00Average Price Target$29.00Lowest Price TargetLowest$23.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Sara Nik | H.C. Wainwright | $23 | buy | 293.84%Upside | Reiterated | 10/26/26 | ||
| Brian Cheng | J.P. Morgan | ― | buy | ― | Reiterated | 10/26/26 | ||
| Jason Zemansky | Bank of America Securities | $32 | buy | 447.95%Upside | Reiterated | 10/19/26 | ||
| Sean Laaman | Morgan Stanley | $32 | buy | 447.95%Upside | Assigned | 08/17/26 | ||
| Robert Driscoll | Wedbush | $7→$5 | sell | -14.38%Downside | Reiterated | 05/12/26 | ||
| Joseph Catanzaro | Mizuho Securities | $26 | buy | 345.21%Upside | Initiated | 03/02/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Sara NikH.C. Wainwright | BuyReiterated$23 | 10/26/26 | 293.84%Upside | ||
| Brian ChengJ.P. Morgan | BuyReiterated | 10/26/26 | ― | ||
| Jason ZemanskyBank of America Securities | BuyReiterated$32 | 10/19/26 | 447.95%Upside | ||
| Sean LaamanMorgan Stanley | BuyAssigned$32 | 08/17/26 | 447.95%Upside | ||
| Robert DriscollWedbush | SellReiterated$7→$5 | 05/12/26 | -14.38%Downside | ||
| Joseph CatanzaroMizuho Securities | BuyInitiated$26 | 03/02/26 | 345.21%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Eikon Therapeutics, Inc.
3 Months
Success Rate2/3 ratings generated profit
67%
Average Return
+4.57%
Copying Robert Driscoll's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.57% per trade.
1 Year
Success Rate3/3 ratings generated profit
100%
Average Return
+51.77%
Copying Robert Driscoll's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +51.77% per trade.
2 Years
Success Rate3/3 ratings generated profit
100%
Average Return
+51.77%
Copying Robert Driscoll's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.77% per trade.
EIKN Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 6 | 4 |
| Buy | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 |
| total | 5 | 3 | 3 | 7 | 5 |
In the current month, EIKN has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EIKN average Analyst price target in the past 3 months is 29.00.
EIKN Financial Forecast
EIKN Stock Forecast FAQ
What is EIKN’s average 12-month price target, according to analysts?
Based on analyst ratings, Eikon Therapeutics, Inc.’s 12-month average price target is $29.00.
What is EIKN’s upside potential, based on the analysts’ average price target?
Eikon Therapeutics, Inc. has 396.58% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is EIKN a Buy, Sell or Hold?
Eikon Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Eikon Therapeutics, Inc.’s price target?
The average price target for Eikon Therapeutics, Inc. is $29.00. This is based on 4 12-month price targets, issued in the past 3 months. The highest analyst price target is $32.00, the lowest forecast is $23.00. The average price target represents a 396.58% increase from the current price of $5.84.
What do analysts say about Eikon Therapeutics, Inc.?
Eikon Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of EIKN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
